Clinical Trial Update: Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated three doses of DVS SR in outpatients with major depressive disorder using paroxetine as a reference drug. The study is completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• DVS SR
• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2013-11-04